Patent Search Methodology Comprehensive patent landscaping was conducted until July 13, 2024 to identify granted patents (currently active and expired) and patent applications (currently pending and abandoned) at the United States Patent and Trademark Office (USPTO) for the drug products Ozempic, Rybelsus and Wegovy (semaglutide) and Mounjaro and Zepbound (tirzepatide)
The Ozempic MDL is titled In re: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation , MDL No
My family thought I was getting ready to die. Around the same time she stopped taking Ozempic, Barber was diagnosed with gastroparesis: a condition also known as stomach paralysis that causes the stomach muscles to stop moving food through the digestive tract effectively, potentially leading to vomiting and a number of other GI symptoms
Kothapalli, R., Aya-ay, J
In 2021, the FDA approved Wegovy, a version of the drug with a higher GLP-1 concentration, for weight management purposes
This combination creates conditions favorable for gallstone formation